Clinical Trials
Showing of 32 results
University Hospitals Seidman Cancer Center researchers Demonstrate Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation
Lead author, Dr. Angela Jia, MD, PhD, presented randomized Phase III results at ASTRO 2026.
University Hospitals Seidman Cancer Center hosts first international pre-launch event for Siemens Healthineers new Accela
University Hospitals Seidman Cancer Center hosted a contingent of international journalists, along with Siemens Healthineers, for the first pre-launch event for the highly anticipated Accela.
Scientists Turn COVID-19 Immune Memory into a Powerful New Ally Against Cancer
Celloram, Inc., University Hospitals and Case Western Reserve University unveil PROTEXI, a novel cancer vaccine platform advancing toward first-in-human clinical trials in sarcoma patients.
UH Seidman Cancer Center researchers to test a gut microbiome intervention as part of a cancer therapy regimen
The S2419 BioFront study is chaired by medical oncologist and Miggo Family Chair in Cancer Research, Pedro Barata, MD, M.Sc.
What prevents more cancer patients from enrolling in potentially life-saving clinical trials?
Financial barriers are biggest hurdle, according to new Case Western Reserve University and University Hospitals study.
Support from Harrington Discovery Institute at University Hospitals Helped Advance Heart Attack Drug into Clinical Trials
Positive results of zalunfiban announced at AHA Scientific Sessions.
Randomized Clinical Trial Led by University Hospitals Seidman Cancer Center Oncologist Leads to Practice-Changing Precision Prostate Cancer Therapy
Randomized trial validates first biomarker tool to guide hormone treatment decisions, allowing for more personalized prostate cancer care.
Kathy Coleman Commits Additional $3.5 Million to Fuel the Future of Clinical Trials at University Hospitals Seidman Cancer Center
UH plans to triple clinical trials capacity by 2030.